Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?

por Borovcanin, Milica Milovan, Jovanovic, Ivan, Radosavljevic, Gordana, Pantic, Jelena, Minic Janicijevic, Slavica, Arsenijevic, Nebojsa, Lukic, Miodrag L.
Publicado 2017

Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia

por Borovcanin, Milica M., Minic Janicijevic, Slavica, Jovanovic, Ivan P., Gajovic, Nevena M., Jurisevic, Milena M., Arsenijevic, Nebojsa N.
Publicado 2020

Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition

por Minic Janicijevic, Slavica, Jovanovic, Ivan P, Gajovic, Nevena M, Jurisevic, Milena M, Debnath, Monojit, Arsenijevic, Nebojsa N, Borovcanin, Milica M
Publicado 2022